APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lancets

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.

These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

Selected research

Industry Growth & Trends

Global Lancets Industry Growth and Trends Forecast to 2032

1 January 2026123 pages

Choose your research edition.

Industry ResearchLancets Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Lancets Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Lancets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lancets Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Lancets Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.

These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

The major players in global Lancets market include Roche, Lifescan, BD, etc. The top 3 players occupy about 30% shares of the global market. Europe and North America are main markets, they occupy about 70% of the global market. Homecare Lancets is the main type, with a share about 80%. Glucose Tests is the main application, which holds a share about 70%.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Lancets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lancets market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lancets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lancets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lancets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lancets Market by Company

Roche

Lifescan

BD

Bayer

Abbott

B. Braun

ARKRAY

Terumo

I-SENS

Nipro

Omron

Infopia

AgaMatrix

Smiths Medical

Sarstedt

SANNUO

Yicheng

Yuwell

Greiner Bio One

Edan

Narang Medical

Lancets Segment by Type

Safety Lancets

Homecare Lancets

Lancets Segment by Application

Cholesterol Tests

Glucose Tests

Others

Lancets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lancets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lancets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lancets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lancets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Safety Lancets Table 2. Major Company of Homecare Lancets Table 3. Global Lancets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Lancets Sales by Type (2021-2026) & (M Units) Table 5. Global Lancets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Lancets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Lancets Sales Market Share in Value by Type (2021-2026) Table 8. Global Lancets Price by Type (2021-2026) & (US$/K Units) Table 9. Global Lancets Sales by Type (2027-2032) & (M Units) Table 10. Global Lancets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Lancets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Lancets Sales Market Share in Value by Type (2027-2032) Table 13. Global Lancets Price by Type (2027-2032) & (US$/K Units) Table 14. North America Lancets Sales by Type (2021-2026) & (M Units) Table 15. North America Lancets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Lancets Sales by Type (2021-2026) & (M Units) Table 17. Europe Lancets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Lancets Sales by Type (2021-2026) & (M Units) Table 19. Asia-Pacific Lancets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Lancets Sales by Type (2021-2026) & (M Units) Table 21. Latin America Lancets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Lancets Sales by Type (2021-2026) & (M Units) Table 23. Middle East and Africa Lancets Sales by Type (2021-2026) & (US$ Million) Table 24. Lancets Industry Trends Table 25. Lancets Industry Drivers Table 26. Lancets Industry Opportunities and Challenges Table 27. Lancets Industry Restraints Table 28. Global Lancets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Lancets Revenue Market Share by Company (2021-2026) Table 30. Global Lancets Sales by Company (2021-2026) & (M Units) Table 31. Global Lancets Sales Share by Company (2021-2026) Table 32. Global Lancets Market Price by Company (2021-2026) & (US$/K Units) Table 33. Global Lancets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Lancets Major Company Production Sites and Headquarters Table 35. Global Lancets Company, Product Type & Application Table 36. Global Lancets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Lancets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Lancets Sales by Region (2021-2026) & (M Units) Table 41. Global Lancets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Lancets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Lancets Sales Market Share in Value by Region (2021-2026) Table 44. Global Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 45. Global Lancets Sales by Region (2027-2032) & (M Units) Table 46. Global Lancets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Lancets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Lancets Sales Market Share in Value by Region (2027-2032) Table 49. Global Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2027-2032) Table 50. Global Lancets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Lancets Sales by Application (2021-2026) & (M Units) Table 52. Global Lancets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Lancets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Lancets Sales Market Share in Value by Application (2021-2026) Table 55. Global Lancets Price by Application (2021-2026) & (US$/K Units) Table 56. Global Lancets Sales by Application (2027-2032) & (M Units) Table 57. Global Lancets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Lancets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Lancets Sales Market Share in Value by Application (2027-2032) Table 60. Global Lancets Price by Application (2027-2032) & (US$/K Units) Table 61. North America Lancets Sales by Application (2021-2026) & (M Units) Table 62. North America Lancets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Lancets Sales by Application (2021-2026) & (M Units) Table 64. Europe Lancets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Lancets Sales by Application (2021-2026) & (M Units) Table 66. Asia-Pacific Lancets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Lancets Sales by Application (2021-2026) & (M Units) Table 68. Latin America Lancets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Lancets Sales by Application (2021-2026) & (M Units) Table 70. Middle East and Africa Lancets Sales by Application (2021-2026) & (US$ Million) Table 71. Roche Company Information Table 72. Roche Business Overview Table 73. Roche Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 74. Roche Lancets Product Portfolio Table 75. Roche Recent Development Table 76. Lifescan Company Information Table 77. Lifescan Business Overview Table 78. Lifescan Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 79. Lifescan Lancets Product Portfolio Table 80. Lifescan Recent Development Table 81. BD Company Information Table 82. BD Business Overview Table 83. BD Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 84. BD Lancets Product Portfolio Table 85. BD Recent Development Table 86. Bayer Company Information Table 87. Bayer Business Overview Table 88. Bayer Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 89. Bayer Lancets Product Portfolio Table 90. Bayer Recent Development Table 91. Abbott Company Information Table 92. Abbott Business Overview Table 93. Abbott Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 94. Abbott Lancets Product Portfolio Table 95. Abbott Recent Development Table 96. B. Braun Company Information Table 97. B. Braun Business Overview Table 98. B. Braun Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 99. B. Braun Lancets Product Portfolio Table 100. B. Braun Recent Development Table 101. ARKRAY Company Information Table 102. ARKRAY Business Overview Table 103. ARKRAY Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 104. ARKRAY Lancets Product Portfolio Table 105. ARKRAY Recent Development Table 106. Terumo Company Information Table 107. Terumo Business Overview Table 108. Terumo Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 109. Terumo Lancets Product Portfolio Table 110. Terumo Recent Development Table 111. I-SENS Company Information Table 112. I-SENS Business Overview Table 113. I-SENS Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 114. I-SENS Lancets Product Portfolio Table 115. I-SENS Recent Development Table 116. Nipro Company Information Table 117. Nipro Business Overview Table 118. Nipro Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 119. Nipro Lancets Product Portfolio Table 120. Nipro Recent Development Table 121. Omron Company Information Table 122. Omron Business Overview Table 123. Omron Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 124. Omron Lancets Product Portfolio Table 125. Omron Recent Development Table 126. Infopia Company Information Table 127. Infopia Business Overview Table 128. Infopia Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 129. Infopia Lancets Product Portfolio Table 130. Infopia Recent Development Table 131. AgaMatrix Company Information Table 132. AgaMatrix Business Overview Table 133. AgaMatrix Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 134. AgaMatrix Lancets Product Portfolio Table 135. AgaMatrix Recent Development Table 136. Smiths Medical Company Information Table 137. Smiths Medical Business Overview Table 138. Smiths Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 139. Smiths Medical Lancets Product Portfolio Table 140. Smiths Medical Recent Development Table 141. Sarstedt Company Information Table 142. Sarstedt Business Overview Table 143. Sarstedt Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 144. Sarstedt Lancets Product Portfolio Table 145. Sarstedt Recent Development Table 146. SANNUO Company Information Table 147. SANNUO Business Overview Table 148. SANNUO Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 149. SANNUO Lancets Product Portfolio Table 150. SANNUO Recent Development Table 151. Yicheng Company Information Table 152. Yicheng Business Overview Table 153. Yicheng Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 154. Yicheng Lancets Product Portfolio Table 155. Yicheng Recent Development Table 156. Yuwell Company Information Table 157. Yuwell Business Overview Table 158. Yuwell Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 159. Yuwell Lancets Product Portfolio Table 160. Yuwell Recent Development Table 161. Greiner Bio One Company Information Table 162. Greiner Bio One Business Overview Table 163. Greiner Bio One Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 164. Greiner Bio One Lancets Product Portfolio Table 165. Greiner Bio One Recent Development Table 166. Edan Company Information Table 167. Edan Business Overview Table 168. Edan Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 169. Edan Lancets Product Portfolio Table 170. Edan Recent Development Table 171. Narang Medical Company Information Table 172. Narang Medical Business Overview Table 173. Narang Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 174. Narang Medical Lancets Product Portfolio Table 175. Narang Medical Recent Development Table 176. North America Lancets Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 177. North America Lancets Sales by Country (2021-2026) & (M Units) Table 178. North America Lancets Sales Market Share by Country (2021-2026) Table 179. North America Lancets Sales Forecast by Country (2027-2032) & (M Units) Table 180. North America Lancets Sales Market Share Forecast by Country (2027-2032) Table 181. North America Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. North America Lancets Market Size by Country (2021-2026) & (US$ Million) Table 183. North America Lancets Market Share by Country (2021-2026) Table 184. North America Lancets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. North America Lancets Market Share Forecast by Country (2027-2032) Table 186. Europe Lancets Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 187. Europe Lancets Sales by Country (2021-2026) & (M Units) Table 188. Europe Lancets Sales Market Share by Country (2021-2026) Table 189. Europe Lancets Sales Forecast by Country (2027-2032) & (M Units) Table 190. Europe Lancets Sales Market Share Forecast by Country (2027-2032) Table 191. Europe Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Europe Lancets Market Size by Country (2021-2026) & (US$ Million) Table 193. Europe Lancets Market Share by Country (2021-2026) Table 194. Europe Lancets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Europe Lancets Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Lancets Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Lancets Sales by Country (2021-2026) & (M Units) Table 198. Asia-Pacific Lancets Sales Market Share by Country (2021-2026) Table 199. Asia-Pacific Lancets Sales Forecast by Country (2027-2032) & (M Units) Table 200. Asia-Pacific Lancets Sales Market Share Forecast by Country (2027-2032) Table 201. Asia-Pacific Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Asia-Pacific Lancets Market Size by Country (2021-2026) & (US$ Million) Table 203. Asia-Pacific Lancets Market Share by Country (2021-2026) Table 204. Asia-Pacific Lancets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Asia-Pacific Lancets Market Share Forecast by Country (2027-2032) Table 206. Latin America Lancets Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 207. Latin America Lancets Sales by Country (2021-2026) & (M Units) Table 208. Latin America Lancets Sales Market Share by Country (2021-2026) Table 209. Latin America Lancets Sales Forecast by Country (2027-2032) & (M Units) Table 210. Latin America Lancets Sales Market Share Forecast by Country (2027-2032) Table 211. Latin America Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Latin America Lancets Market Size by Country (2021-2026) & (US$ Million) Table 213. Latin America Lancets Market Share by Country (2021-2026) Table 214. Latin America Lancets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Latin America Lancets Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Lancets Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Lancets Sales by Country (2021-2026) & (M Units) Table 218. Middle East and Africa Lancets Sales Market Share by Country (2021-2026) Table 219. Middle East and Africa Lancets Sales Forecast by Country (2027-2032) & (M Units) Table 220. Middle East and Africa Lancets Sales Market Share Forecast by Country (2027-2032) Table 221. Middle East and Africa Lancets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. Middle East and Africa Lancets Market Size by Country (2021-2026) & (US$ Million) Table 223. Middle East and Africa Lancets Market Share by Country (2021-2026) Table 224. Middle East and Africa Lancets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. Middle East and Africa Lancets Market Share Forecast by Country (2027-2032) Table 226. Key Raw Materials Table 227. Raw Materials Key Suppliers Table 228. Lancets Distributors List Table 229. Lancets Customers List Table 230. Research Programs/Design for This Report Table 231. Authors List of This Report Table 232. Secondary Sources Table 233. Primary Sources List of Figures Figure 1. Lancets Image Figure 2. Global Lancets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lancets Market Size (2021-2032) & (US$ Million) Figure 4. Global Lancets Sales (2021-2032) & (M Units) Figure 5. Safety Lancets Image Figure 6. Global Safety Lancets Sales YoY Growth (2021-2032) & (M Units) Figure 7. Homecare Lancets Image Figure 8. Global Homecare Lancets Sales YoY Growth (2021-2032) & (M Units) Figure 9. Global Lancets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Lancets Market Share by Type 2025 VS 2032 Figure 11. North America Lancets Sales Market Share in Volume by Type in 2025 Figure 12. North America Lancets Sales Market Share in Value by Type in 2025 Figure 13. Europe Lancets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Lancets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Lancets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Lancets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Lancets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Lancets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Lancets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Lancets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Lancets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cholesterol Tests Image Figure 24. Global Cholesterol Tests Sales YoY Growth (2021-2032) & (M Units) Figure 25. Glucose Tests Image Figure 26. Global Glucose Tests Sales YoY Growth (2021-2032) & (M Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 29. Global Lancets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Lancets Market Share by Application 2025 VS 2032 Figure 31. North America Lancets Sales Market Share in Volume by Application in 2025 Figure 32. North America Lancets Sales Market Share in Value by Application in 2025 Figure 33. Europe Lancets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Lancets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Lancets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Lancets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Lancets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Lancets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Lancets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Lancets Sales Market Share in Value by Application in 2025 Figure 41. North America Lancets Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 42. North America Lancets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Lancets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Lancets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Lancets Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 46. Europe Lancets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Lancets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Lancets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Lancets Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 50. Asia-Pacific Lancets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Lancets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Lancets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Lancets Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. Latin America Lancets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Lancets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Lancets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Lancets Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Middle East and Africa Lancets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Lancets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Lancets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Lancets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Lancets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Safety Lancets
  • Homecare Lancets
Applications
  • Cholesterol Tests
  • Glucose Tests
  • Others
Companies covered
  • Roche
  • Lifescan
  • BD
  • Bayer
  • Abbott
  • B. Braun
  • ARKRAY
  • Terumo
  • I-SENS
  • Nipro
  • Omron
  • Infopia
  • AgaMatrix
  • Smiths Medical
  • Sarstedt
  • SANNUO
  • Yicheng
  • Yuwell
  • Greiner Bio One
  • Edan
  • Narang Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lancets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lancets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lancets Market by Type
  6. 1.3.1 Safety Lancets
  7. 1.3.2 Homecare Lancets
  8. 1.4 Global Lancets Market Size by Type
  9. 1.4.1 Global Lancets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Lancets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Lancets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Lancets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Lancets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Lancets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Lancets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Lancets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lancets Industry Trends
  2. 2.2 Lancets Industry Drivers
  3. 2.3 Lancets Industry Opportunities and Challenges
  4. 2.4 Lancets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lancets Revenue (2021-2026)
  2. 3.2 Global Top Players by Lancets Sales (2021-2026)
  3. 3.3 Global Top Players by Lancets Price (2021-2026)
  4. 3.4 Global Lancets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lancets Major Company Production Sites & Headquarters
  6. 3.6 Global Lancets Company, Product Type & Application
  7. 3.7 Global Lancets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lancets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lancets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lancets Tier 1, Tier 2, and Tier 3
4 Lancets Regional Status and Outlook
  1. 4.1 Global Lancets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lancets Historic Market Size by Region
  3. 4.2.1 Global Lancets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lancets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lancets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lancets Forecasted Market Size by Region
  7. 4.3.1 Global Lancets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lancets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lancets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lancets by Application
  1. 5.1 Lancets Market by Application
  2. 5.1.1 Cholesterol Tests
  3. 5.1.2 Glucose Tests
  4. 5.1.3 Others
  5. 5.2 Global Lancets Market Size by Application
  6. 5.2.1 Global Lancets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Lancets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Lancets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Lancets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Lancets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Lancets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Lancets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Lancets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Lancets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Roche Lancets Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Lifescan
  8. 6.2.1 Lifescan Company Information
  9. 6.2.2 Lifescan Business Overview
  10. 6.2.3 Lifescan Lancets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Lifescan Lancets Product Portfolio
  12. 6.2.5 Lifescan Recent Developments
  13. 6.3 BD
  14. 6.3.1 BD Company Information
  15. 6.3.2 BD Business Overview
  16. 6.3.3 BD Lancets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BD Lancets Product Portfolio
  18. 6.3.5 BD Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Lancets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Lancets Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 Abbott
  26. 6.5.1 Abbott Company Information
  27. 6.5.2 Abbott Business Overview
  28. 6.5.3 Abbott Lancets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Abbott Lancets Product Portfolio
  30. 6.5.5 Abbott Recent Developments
  31. 6.6 B. Braun
  32. 6.6.1 B. Braun Company Information
  33. 6.6.2 B. Braun Business Overview
  34. 6.6.3 B. Braun Lancets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 B. Braun Lancets Product Portfolio
  36. 6.6.5 B. Braun Recent Developments
  37. 6.7 ARKRAY
  38. 6.7.1 ARKRAY Company Information
  39. 6.7.2 ARKRAY Business Overview
  40. 6.7.3 ARKRAY Lancets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 ARKRAY Lancets Product Portfolio
  42. 6.7.5 ARKRAY Recent Developments
  43. 6.8 Terumo
  44. 6.8.1 Terumo Company Information
  45. 6.8.2 Terumo Business Overview
  46. 6.8.3 Terumo Lancets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Terumo Lancets Product Portfolio
  48. 6.8.5 Terumo Recent Developments
  49. 6.9 I-SENS
  50. 6.9.1 I-SENS Company Information
  51. 6.9.2 I-SENS Business Overview
  52. 6.9.3 I-SENS Lancets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 I-SENS Lancets Product Portfolio
  54. 6.9.5 I-SENS Recent Developments
  55. 6.10 Nipro
  56. 6.10.1 Nipro Company Information
  57. 6.10.2 Nipro Business Overview
  58. 6.10.3 Nipro Lancets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Nipro Lancets Product Portfolio
  60. 6.10.5 Nipro Recent Developments
  61. 6.11 Omron
  62. 6.11.1 Omron Company Information
  63. 6.11.2 Omron Business Overview
  64. 6.11.3 Omron Lancets Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Omron Lancets Product Portfolio
  66. 6.11.5 Omron Recent Developments
  67. 6.12 Infopia
  68. 6.12.1 Infopia Company Information
  69. 6.12.2 Infopia Business Overview
  70. 6.12.3 Infopia Lancets Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Infopia Lancets Product Portfolio
  72. 6.12.5 Infopia Recent Developments
  73. 6.13 AgaMatrix
  74. 6.13.1 AgaMatrix Company Information
  75. 6.13.2 AgaMatrix Business Overview
  76. 6.13.3 AgaMatrix Lancets Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 AgaMatrix Lancets Product Portfolio
  78. 6.13.5 AgaMatrix Recent Developments
  79. 6.14 Smiths Medical
  80. 6.14.1 Smiths Medical Company Information
  81. 6.14.2 Smiths Medical Business Overview
  82. 6.14.3 Smiths Medical Lancets Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Smiths Medical Lancets Product Portfolio
  84. 6.14.5 Smiths Medical Recent Developments
  85. 6.15 Sarstedt
  86. 6.15.1 Sarstedt Company Information
  87. 6.15.2 Sarstedt Business Overview
  88. 6.15.3 Sarstedt Lancets Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sarstedt Lancets Product Portfolio
  90. 6.15.5 Sarstedt Recent Developments
  91. 6.16 SANNUO
  92. 6.16.1 SANNUO Company Information
  93. 6.16.2 SANNUO Business Overview
  94. 6.16.3 SANNUO Lancets Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 SANNUO Lancets Product Portfolio
  96. 6.16.5 SANNUO Recent Developments
  97. 6.17 Yicheng
  98. 6.17.1 Yicheng Company Information
  99. 6.17.2 Yicheng Business Overview
  100. 6.17.3 Yicheng Lancets Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Yicheng Lancets Product Portfolio
  102. 6.17.5 Yicheng Recent Developments
  103. 6.18 Yuwell
  104. 6.18.1 Yuwell Company Information
  105. 6.18.2 Yuwell Business Overview
  106. 6.18.3 Yuwell Lancets Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Yuwell Lancets Product Portfolio
  108. 6.18.5 Yuwell Recent Developments
  109. 6.19 Greiner Bio One
  110. 6.19.1 Greiner Bio One Company Information
  111. 6.19.2 Greiner Bio One Business Overview
  112. 6.19.3 Greiner Bio One Lancets Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Greiner Bio One Lancets Product Portfolio
  114. 6.19.5 Greiner Bio One Recent Developments
  115. 6.20 Edan
  116. 6.20.1 Edan Company Information
  117. 6.20.2 Edan Business Overview
  118. 6.20.3 Edan Lancets Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Edan Lancets Product Portfolio
  120. 6.20.5 Edan Recent Developments
  121. 6.21 Narang Medical
  122. 6.21.1 Narang Medical Company Information
  123. 6.21.2 Narang Medical Business Overview
  124. 6.21.3 Narang Medical Lancets Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Narang Medical Lancets Product Portfolio
  126. 6.21.5 Narang Medical Recent Developments
7 North America by Country
  1. 7.1 North America Lancets Sales by Country
  2. 7.1.1 North America Lancets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lancets Sales by Country (2021-2026)
  4. 7.1.3 North America Lancets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lancets Market Size by Country
  6. 7.2.1 North America Lancets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lancets Market Size by Country (2021-2026)
  8. 7.2.3 North America Lancets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lancets Sales by Country
  2. 8.1.1 Europe Lancets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lancets Sales by Country (2021-2026)
  4. 8.1.3 Europe Lancets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lancets Market Size by Country
  6. 8.2.1 Europe Lancets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lancets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lancets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lancets Sales by Country
  2. 9.1.1 Asia-Pacific Lancets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lancets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lancets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lancets Market Size by Country
  6. 9.2.1 Asia-Pacific Lancets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lancets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lancets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lancets Sales by Country
  2. 10.1.1 South America Lancets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lancets Sales by Country (2021-2026)
  4. 10.1.3 South America Lancets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lancets Market Size by Country
  6. 10.2.1 South America Lancets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lancets Market Size by Country (2021-2026)
  8. 10.2.3 South America Lancets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lancets Sales by Country
  2. 11.1.1 Middle East and Africa Lancets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lancets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lancets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lancets Market Size by Country
  6. 11.2.1 Middle East and Africa Lancets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lancets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lancets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lancets Value Chain Analysis
  2. 12.1.1 Lancets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lancets Production Mode & Process
  7. 12.2 Lancets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lancets Distributors
  10. 12.2.3 Lancets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst